Back to Rosalind Advisors, Inc.
Q2 2026 13F filing
Updated 27 days ago35 disclosed positions worth $269.2M
Portfolio value
$269.2M
Total holdings
35
New positions
0
Closed positions
0
Increased
0
Decreased
0
Turnover
—
Filed
2026-08-14
Full holdings
Every line item disclosed in Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | D DCTH DELCATH SYSTEMS, INC. | $41.6M | 3.30M | 15.44% | — |
| 2 | F FENC FENNEC PHARMACEUTICALS INC | $34.3M | 3.19M | 12.73% | — |
| 3 | X XERS XERIS BIOPHARMA HOLDINGS INC | $23M | 2.91M | 8.56% | — |
| 4 | S SVRA SAVARA INC | $19.6M | 3.18M | 7.27% | — |
| 5 | V VSTM VERASTEM INC | $15.2M | 3.99M | 5.66% | — |
| 6 | ? N/A X4 PHARMACEUTICALS INC | $15M | 3.21M | 5.58% | — |
| 7 | ? N/A EYEPOINT PHARMACEUTICALS INC | $14.1M | 988.2K | 5.25% | — |
| 8 | H HELP CYBIN INC | $12.9M | 1.96M | 4.80% | — |
| 9 | V VOR VOR BIOPHARMA INC | $11.9M | 648.6K | 4.44% | — |
| 10 | P PCVX VAXCYTE INC | $11.6M | 200.0K | 4.32% | — |
| 11 | M MDWD MEDIWOUND LTD | $11M | 749.1K | 4.09% | — |
| 12 | C CLDX CELLDEX THERAPEUTICS INC | $7.4M | 200.0K | 2.76% | — |
| 13 | B BCRX BIOCRYST PHARMACEUTICALS INC | $7.2M | 721.5K | 2.68% | — |
| 14 | P PROF PROFOUND MEDICAL CORP | $5.5M | 828.1K | 2.05% | — |
| 15 | ? N/A TALPHERA INC | $5.3M | 5.17M | 1.98% | — |
| 16 | A AVIR ATEA PHARMACEUTICALS INC | $5M | 1.07M | 1.85% | — |
| 17 | ? N/A MYOMO INC | $3.8M | 3.64M | 1.41% | — |
| 18 | O OVID OVID THERAPEUTICS INC | $3M | 1.11M | 1.11% | — |
| 19 | N NRXS NEURAXIS INC | $3M | 508.1K | 1.10% | — |
| 20 | A AAVXF ABIVAX SA | $2.8M | 20.9K | 1.03% | — |
| 21 | ? N/A INSPIREMD INC | $2.7M | 3.91M | 1.02% | — |
| 22 | R RGNT REGENTIS BIOMATERIALS LTD | $2.5M | 701.7K | 0.92% | — |
| 23 | ? N/A SELLAS LIFE SCIENCES GROUP INC | $2.3M | 568.7K | 0.86% | — |
| 24 | P PYPD POLYPID LTD | $2M | 389.5K | 0.73% | — |
| 25 | B BFRIW BIOFRONTERA INC | $1.2M | 1.28M | 0.45% | — |
| 26 | K KURA KURA ONCOLOGY INC | $1.1M | 100.0K | 0.41% | — |
| 27 | S SPRB SPRUCE BIOSCIENCES INC | $1.1M | 20.0K | 0.40% | — |
| 28 | A AQST AQUESTIVE THERAPEUTICS INC | $1M | 250.0K | 0.39% | — |
| 29 | O OKUR ONKURE THERAPEUTICS INC | $684K | 150.0K | 0.25% | — |
| 30 | P PEPG PEPGEN INC | $630K | 350.0K | 0.23% | — |
| 31 | ? N/A CG ONCOLOGY INC | $375K | 31.0K | 0.14% | — |
| 32 | ? N/A EYEPOINT PHARMACEUTICALS INC | $131K | 50.3K | 0.05% | — |
| 33 | ? N/A ISHARES TR | $110K | 500.0K | 0.04% | — |
| 34 | ? N/A SPDR SERIES TRUST | $35K | 140.6K | 0.01% | — |
| 35 | ? N/A TENAX THERAPEUTICS INC | $14K | 6.2K | 0.01% | — |